title: Coexistent adenoviral keratoconjunctivitis and Acanthamoeba keratitis.
abstract: A 17-year-old youth presented with bilateral follicular conjunctivitis and nummular subepithelial corneal infiltrates. Failure of this to settle in an outpatient setting led to corneal scraping with microscopy and culturing for bacteria, fungi, Herpes simplex, adenovirus and Acanthamoeba as an inpatient. Polymerase chain reaction analysis of corneal cells was positive for adenovirus, and culture on live Escherichia coli-coated agar plates was positive for Acanthamoeba by phase contrast microscopy on day two. We conclude that Acanthomoeba infection can complicate adenoviral keratoconjunctivitis. This observation is in keeping with previously reported modes of infection by Acanthamoeba, whereby any epithelial breach seems to allow inoculation of the eye by this opportunistic organism.
authors.affiliation: Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. gajdatsy@global.net.au
authors.forename: A D
authors.initials: AD
authors.lastname: Gajdatsy
authors.forename: A
authors.initials: A
authors.lastname: Kosmin
authors.forename: G D
authors.initials: GD
authors.lastname: Barrett
mesh_terms: D000048:Acanthamoeba / Q000302:isolation & purification; D015823:Acanthamoeba Keratitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000212:Acyclovir / Q000627:therapeutic use; D000258:Adenovirus Infections, Human / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000260:Adenoviruses, Human / Q000302:isolation & purification; D000293:Adolescent; D000818:Animals; D001645:Biguanides / Q000627:therapeutic use; D003519:Cyclopentolate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015828:Eye Infections, Viral / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007637:Keratoconjunctivitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology; D008297:Male; D011239:Prednisolone / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001645:Biguanides; C031233:polihexanide; C009022:prednisolone phosphate; D011239:Prednisolone; D003519:Cyclopentolate; D000212:Acyclovir